Ratings by TD Cowen (Chris Shibutani)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/12/2024 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Nektar Therapeutics | NKTR | Upgrade | Buy (Hold) |
0.50 (72.21) |
14342% | Details | |
| 11/3/2023 | Puma Biotechnology | PBYI | Maintain | Hold (N/A) |
|
Details | ||
| 3/15/2022 | Nektar Therapeutics | NKTR | Downgrade | Hold (Buy) |
10.63 (64.46) |
506.4% | Details | |
| 11/6/2020 | Puma Biotechnology | PBYI | Maintain | Hold (N/A) |
|
Details | ||
| 8/10/2020 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2020 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | Nkarta Inc. | NKTX | New Coverage | Buy (N/A) |
26.58 (2.93) |
-88.98% | Details | |
| 7/29/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2020 | Viela Bio | VIE | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2020 | Revolution | RVMD | New Coverage | Buy (N/A) |
31.96 (167.83) |
425.13% | Details | |
| 2/27/2020 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Hold) |
105.81 (546.84) |
416.81% | Details | |
| 2/21/2020 | Puma Biotechnology | PBYI | Maintain | Hold (N/A) |
|
Details | ||
| 2/14/2020 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2020 | Ardelyx, Inc | ARDX | New Coverage | Buy (N/A) |
7.18 (6.22) |
-13.37% | Details | |
| 1/24/2020 | Puma Biotechnology | PBYI | Maintain | Hold (N/A) |
|
Details | ||
| 1/10/2020 | Aduro Biotech | ADRO | Downgrade | Hold (Buy) |
1.39 (14.60) |
950.36% | Details | |
| 11/26/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2019 | Puma Biotechnology | PBYI | Maintain | Hold (N/A) |
|
Details | ||
| 10/31/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2019 | United Therapeutics Corp. | UTHR | Maintain | Hold (N/A) |
|
Details | ||
| 10/28/2019 | Viela Bio | VIE | New Coverage | Buy (N/A) |
20.52 (53.01) |
158.33% | Details | |
| 10/24/2019 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2019 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2019 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2019 | The Medicines Company | MDCO | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2019 | Puma Biotechnology | PBYI | Maintain | Hold (N/A) |
|
Details | ||
| 8/2/2019 | United Therapeutics Corp. | UTHR | Maintain | Hold (N/A) |
|
Details | ||
| 7/26/2019 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 7/5/2019 | Puma Biotechnology | PBYI | Maintain | Hold (Hold) |
|
Details | ||
| 6/19/2019 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2019 | Puma Biotechnology | PBYI | Maintain | Hold (Hold) |
|
Details | ||
| 5/10/2019 | Puma Biotechnology | PBYI | Maintain | Hold (N/A) |
|
Details | ||
| 2/15/2019 | Alkermes | ALKS | Maintain | Buy (Buy) |
|
Details | ||
| 2/6/2019 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 1/15/2019 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2018 | Achaogen | AKAO | Downgrade | Hold (Buy) |
3.08 (0.11) |
-96.43% | Details | |
| 11/2/2018 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2018 | United Therapeutics Corp. | UTHR | Maintain | Hold (N/A) |
|
Details |
